Skip to content

Coronary Heart Disease Risk Reduction

Coronary heart disease risk reduction is the effort to slow the build-up of plaque in the heart’s arteries before a heart attack or stroke occurs.

Lopid

Gemfibrozil

300mg

Gemfibrozil tablets for high triglycerides and reducing coronary risk. It primarily lowers triglyceride levels rather than LDL.

From$1.68/ tabletView

Key points

  • Coronary heart disease risk reduction is often considered for people with elevated cholesterol or other factors that contribute to arterial narrowing.
  • Gemfibrozil belongs to a group of medicines called fibrates, which help the body manage the fats linked to plaque development.

Common questions about Coronary Heart Disease Risk Reduction

Which medicine is listed for coronary heart disease risk reduction?

The catalogue contains Lopid, a 300mg tablet. It is the only product attached to this topic.

What kind of medicine is Lopid?

Lopid is a fibrate. Its active ingredient, Gemfibrozil, helps the body manage the blood fats connected to plaque build-up in the arteries that supply the heart.

Further reading